Discovery of Nanomolar-Affinity Pharmacological Chaperones Stabilizing the Oncogenic p53 Mutant Y220C. (2022)
Attributed to:
Design, synthesis and Evaluation of Novel Small Molecule Modulators of Cell Signalling in Cancer
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acsptsci.2c00164
PubMed Identifier: 36407959
Publication URI: http://europepmc.org/abstract/MED/36407959
Type: Journal Article/Review
Volume: 5
Parent Publication: ACS pharmacology & translational science
Issue: 11
ISSN: 2575-9108